NCT07079852View on ClinicalTrials.gov

The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Healthy
Interventions
DRUG

Placebo

This is an inactive control condition.

DRUG

Psilocybin 15mg

This is a moderate psychoactive dose.

Trial Locations (1)

78712

The University of Texas at Austin Dell Medical School, Austin

All Listed Sponsors
lead

Manoj Doss

OTHER

NCT07079852 - The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function | Biotech Hunter | Biotech Hunter